Filing Details

Accession Number:
0001214659-13-003594
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-26 17:24:02
Reporting Period:
2013-06-24
Filing Date:
2013-06-26
Accepted Time:
2013-06-26 17:24:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1484500 E. David Thompson C/o Anthera Pharmaceuticals, Inc.,
25801 Industrial Boulevard, Suite B
Hayward CA 94545
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-24 100,000 $0.53 128,201 No 4 P Indirect By David E. Thompson Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By David E. Thompson Revocable Trust